Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8742075 Monoclonal antibodies against ANGPTL3

Patent 8742075 was granted and assigned to Lexicon Pharmaceuticals, Inc. on June, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Lexicon Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Seokjoo Hong0

Xiao Feng0

David Powell0

E-Chiang Lee0

Gregory Landes0

Urvi Desai0

Date of Patent

June 3, 2014

Patent Application Number

13073617

Date Filed

March 28, 2011

Patent Citations Received

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

0

Patent Primary Examiner

Patent abstract

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8742075 Monoclonal antibodies against ANGPTL3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.